Abstract |
Despite the fact that monoamine oxidase inhibitors (MAOIs) can be highly effective therapeutic agents for depression and some anxiety disorders, they tend to be underutilized in clinical practice. This is due at least in part to the fact that there is a great deal of misinformation and mythology about their dietary and drug interactions. This article is intended to serve as a guide for clinicians who are not particularly familiar with MAO inhibitors; its aim is to help these clinicians competently integrate these agents into clinical practice when appropriate.
|
Authors | Meghan M Grady, Stephen M Stahl |
Journal | CNS spectrums
(CNS Spectr)
Vol. 17
Issue 1
Pg. 2-10
(Mar 2012)
ISSN: 1092-8529 [Print] United States |
PMID | 22790112
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Monoamine Oxidase Inhibitors
|
Topics |
- Anxiety Disorders
(drug therapy)
- Depression
(drug therapy)
- Drug Interactions
- Guidelines as Topic
(standards)
- Humans
- Monoamine Oxidase Inhibitors
(pharmacology, therapeutic use)
|